CITIC Capital has secured a carve-out of marketing and e-commerce services player UCO Cosmetics. It exploits an overall slowdown in China’s economy but also relative sturdiness in the local beauty industry
Brands in China have started to fear a so-called consumption downgrade, as buyers cut spending and opt for cheaper goods. When retail sales growth in the country slumped to a 16-year low of 7.2% in April,...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.